| The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria T Zuberbier, W Aberer, R Asero, AH Abdul Latiff, D Baker, ... Allergy 73 (7), 1393-1414, 2018 | 4054* | 2018 |
| The global burden of chronic urticaria for the patient and society M Gonçalo, A Gimenéz‐Arnau, M Al‐Ahmad, M Ben‐Shoshan, ... British Journal of Dermatology 184 (2), 226-236, 2021 | 205 | 2021 |
| Dendritic cell–tumor cell hybrid vaccination for metastatic cancer JAM Barbuto, LFC Ensina, AR Neves, PC Bergami-Santos, KRM Leite, ... Cancer Immunology, Immunotherapy 53, 1111-1118, 2004 | 137 | 2004 |
| Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell–autologous tumor cell hybrids express more CD86 and induce higher levels of … AR Neves, LFC Ensina, LB Anselmo, KRM Leite, AC Buzaid, ... Cancer Immunology, Immunotherapy 54, 61-66, 2005 | 93 | 2005 |
| Drug-induced anaphylaxis in Latin American countries EJ Jares, CE Baena-Cagnani, M Sánchez-Borges, LFC Ensina, ... The Journal of Allergy and Clinical Immunology: in Practice 3 (5), 780-788, 2015 | 92 | 2015 |
| Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy M Sánchez-Borges, B Thong, M Blanca, LFC Ensina, S González-Díaz, ... World Allergy Organization Journal 6, 1-23, 2013 | 91 | 2013 |
| Multinational experience with hypersensitivity drug reactions in Latin America EJ Jares, M Sánchez-Borges, R Cardona-Villa, LF Ensina, A Arias-Cruz, ... Annals of Allergy, Asthma & Immunology 113 (3), 282-289, 2014 | 75 | 2014 |
| The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria E Kocatürk, A Salman, I Cherrez‐Ojeda, PR Criado, J Peter, ... Allergy, 2020 | 68 | 2020 |
| Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry W Francuzik, F Ruëff, A Bauer, MB Bilò, V Cardona, G Christoff, ... Journal of Allergy and Clinical Immunology 147 (2), 653-662. e9, 2021 | 53 | 2021 |
| Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study M Maurer, K Houghton, C Costa, F Dabove, LF Ensina, A Giménez-Arnau, ... World Allergy Organization Journal 11, 32, 2018 | 53 | 2018 |
| The burden of chronic urticaria from Brazilian patients’ perspective MM Balp, N Lopes da Silva, J Vietri, H Tian, LF Ensina Dermatology and therapy 7, 535-545, 2017 | 51 | 2017 |
| Update on omalizumab for urticaria: what’s new in the literature from mechanisms to clinic DES Larenas-Linnemann, CAS Parisi, C Ritchie, R Cardona-Villa, ... Current Allergy and Asthma Reports 18, 1-13, 2018 | 47 | 2018 |
| Peanut‐induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry I Maris, S Dölle‐Bierke, JM Renaudin, L Lange, A Koehli, T Spindler, ... Allergy 76 (5), 1517-1527, 2021 | 45 | 2021 |
| Risk factors and characteristics of biphasic anaphylaxis M Kraft, KS Hofmeier, F Ruëff, C Pföhler, JM Renaudin, MB Bilò, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3388 …, 2020 | 44 | 2020 |
| Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results M Maurer, A Giménez-Arnau, LF Ensina, CY Chu, X Jaumont, P Tassinari World Allergy Organization Journal 13 (9), 100460, 2020 | 40 | 2020 |
| Outcomes and safety of drug provocation tests. MV Aun, C Bisaccioni, LS Garro, AT Rodrigues, LK Tanno, LFC Ensina, ... Allergy & Asthma Proceedings 32 (4), 2011 | 40 | 2011 |
| Reações de hipersensibilidade a medicamentos LF Ensina, FR Fernandes, GD Gesu, MF Malaman, ML Chavarria, ... Rev bras alerg imunopatol 32 (2), 42-47, 2009 | 40 | 2009 |
| Reações de hipersensibilidade a medicamentos LF Ensina, FR Fernandes, GD Gesu, MF Malaman, ML Chavarria, ... Rev bras alerg imunopatol 32 (2), 42-47, 2009 | 40 | 2009 |
| Reações de hipersensibilidade a medicamentos LF Ensina, FR Fernandes, GD Gesu, MF Malaman, ML Chavarria, ... Rev bras alerg imunopatol 32 (2), 42-47, 2009 | 40 | 2009 |
| Omalizumab in chronic spontaneous urticaria: a Brazilian real-life experience LF Ensina, SOR Valle, AP Juliani, M Galeane, R Vieira dos Santos, ... International Archives of Allergy and Immunology 169 (2), 121-124, 2016 | 39 | 2016 |
Marcus MaurerProfessor, Institute of Allergology, Charité - Universitätsmedizin Berlin, GermanyVerified email at charite.de
